KARYOTYPE ANALYSIS OF ADVANCED THERAPY SPECIMENS IN A ROUTINE CYTOGENETIC LABORATORY

Autor: MFMD Santos, RK Kishimoto, RMSO Safranauskas, AAC Coimbra, GSE Silva, JL Silva, RMA Paiva, MS Sielski, E Velloso

Publikováno v: Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S515-S516 (2023)

Objectives: Cytogenetic study is a prerequisite for the therapeutic use of cellular/advanced therapy products required by regulatory agencies (ANVISA). This aims to guarantee the safety and quality of the cells for clinical use, preventing the use of

Externí odkaz: https://doaj.org/article/41579bf333ce446ea3e60d8b93fce26c

An Extended Flow Cytometry Evaluation of ex Vivo Expanded NK Cells Using K562.Clone1, a Feeder Cell Line Manufactured in Brazil.

Autor: Watanabe CM; Experimental Research Laboratory, Hospital Israelita Albert Einstein, São Paulo, Brazil., Suzuki CI; Experimental Research Laboratory, Hospital Israelita Albert Einstein, São Paulo, Brazil., Dos Santos AM; Experimental Research Laboratory, Hospital Israelita Albert Einstein, São Paulo, Brazil., Aloia TPA; Experimental Research Laboratory, Hospital Israelita Albert Einstein, São Paulo, Brazil., Lee G; Department of Pathology, Case Western Reserve University, Cleveland, Ohio., Wald D; Department of Pathology, Case Western Reserve University, Cleveland, Ohio; Department of Pathology, University Hospitals Cleveland Medical Center, Cleveland, Ohio., Okamoto OK; Department of Hemotherapy and Cellular Therapy, Hospital Israelita Albert Einstein, São Paulo, Brazil; Human Genome and Stem Cell Research Center, Department of Genetics and Evolutionary Biology, Biosciences Institute, University of São Paulo, São Paulo, Brazil., de Azevedo JTC; Experimental Research Laboratory, Hospital Israelita Albert Einstein, São Paulo, Brazil; Department of Hemotherapy and Cellular Therapy, Hospital Israelita Albert Einstein, São Paulo, Brazil., de Godoy JAP; Experimental Research Laboratory, Hospital Israelita Albert Einstein, São Paulo, Brazil; Department of Hemotherapy and Cellular Therapy, Hospital Israelita Albert Einstein, São Paulo, Brazil., Santos FPS; Experimental Research Laboratory, Hospital Israelita Albert Einstein, São Paulo, Brazil; Oncology and Hematology Center, Familia Dayan-Daycoval, Hospital Israelita Albert Einstein, São Paulo, Brazil., Weinlich R; Experimental Research Laboratory, Hospital Israelita Albert Einstein, São Paulo, Brazil., Kerbauy LN; Experimental Research Laboratory, Hospital Israelita Albert Einstein, São Paulo, Brazil; Department of Hemotherapy and Cellular Therapy, Hospital Israelita Albert Einstein, São Paulo, Brazil; Oncology and Hematology Center, Familia Dayan-Daycoval, Hospital Israelita Albert Einstein, São Paulo, Brazil., Kutner JM; Department of Hemotherapy and Cellular Therapy, Hospital Israelita Albert Einstein, São Paulo, Brazil; Oncology and Hematology Center, Familia Dayan-Daycoval, Hospital Israelita Albert Einstein, São Paulo, Brazil., Paiva RMA; Experimental Research Laboratory, Hospital Israelita Albert Einstein, São Paulo, Brazil; Department of Hemotherapy and Cellular Therapy, Hospital Israelita Albert Einstein, São Paulo, Brazil. Electronic address: raquel.paiva@einstein.br., Hamerschlak N; Human Genome and Stem Cell Research Center, Department of Genetics and Evolutionary Biology, Biosciences Institute, University of São Paulo, São Paulo, Brazil.

Publikováno v: Transplantation and cellular therapy [Transplant Cell Ther] 2024 Nov; Vol. 30 (11), pp. 1063.e1-1063.e19. Date of Electronic Publication: 2024 Jul 08.

Is the telomere length associated with neurocognitive disabilities in HIV-1-infected subjects?

Autor: Araújo ML; Divisão Dermatologia, Laboratório de Dermatologia e Imunodeficiências, Hospital das Clínicas, Universidade de São Paulo, São Paulo, São Paulo, Brazil., Duarte W; Divisão Dermatologia, Laboratório de Dermatologia e Imunodeficiências, Hospital das Clínicas, Universidade de São Paulo, São Paulo, São Paulo, Brazil., Oliveira ACP; Instituto de Infectologia Emílio Ribas, São Paulo, São Paulo, Brazil., Gascón MRP; Instituto de Infectologia Emílio Ribas, São Paulo, São Paulo, Brazil., Fonseca LAM; Departamento de Medicina Preventiva, Faculdade de Medicina, Universidade de São Paulo, São Paulo, São Paulo, Brazil., Paiva RMA; Departamento de Medicina Interna, Escola de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, São Paulo, Brazil., Santana B; Departamento de Medicina Interna, Escola de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, São Paulo, Brazil., Calado RT; Departamento de Medicina Interna, Escola de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, São Paulo, Brazil., Casseb J; Divisão Dermatologia, Laboratório de Dermatologia e Imunodeficiências, Hospital das Clínicas, Universidade de São Paulo, São Paulo, São Paulo, Brazil.

Publikováno v: Revista do Instituto de Medicina Tropical de Sao Paulo [Rev Inst Med Trop Sao Paulo] 2018; Vol. 60, pp. e16. Date of Electronic Publication: 2018 Apr 23.